BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Diagnosis
8 results:

  • 1. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis.
    Tan C; Li Y; Huang X; Wei M; Huang Y; Tang Z; Huang H; Zhou W; Wang Y; Hu J
    Cell Death Dis; 2019 Dec; 10(12):914. PubMed ID: 31801946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
    Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
    J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.
    Glover AR; Zhao JT; Gill AJ; Weiss J; Mugridge N; Kim E; Feeney AL; Ip JC; Reid G; Clarke S; Soon PS; Robinson BG; Brahmbhatt H; MacDiarmid JA; Sidhu SB
    Oncotarget; 2015 Nov; 6(34):36675-88. PubMed ID: 26452132
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aberrant expression of COT is related to recurrence of papillary thyroid cancer.
    Lee J; Jeong S; Park JH; Lee CR; Ku CR; Kang SW; Jeong JJ; Nam KH; Shin DY; Lee EJ; Chung WY; Jo YS
    Medicine (Baltimore); 2015 Feb; 94(6):e548. PubMed ID: 25674762
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Calcium/Calmodulin-dependent protein kinase II and its endogenous inhibitor α in medullary thyroid cancer.
    Russo E; Salzano M; De Falco V; Mian C; Barollo S; Secondo A; Bifulco M; Vitale M
    Clin Cancer Res; 2014 Mar; 20(6):1513-20. PubMed ID: 24449826
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
    Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis.
    Maher ER; Bentley E; Yates JR; Latif F; Lerman M; Zbar B; Affara NA; Ferguson-Smith MA
    Genomics; 1991 Aug; 10(4):957-60. PubMed ID: 1680799
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.